Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $25.4M | $18.1M | $29.6M | $19.6M |
| Gross profit | — | $10.8M | $7.9M | $13.3M | $8.9M |
| Operating income | -$3.4M | -$2.6M | -$13.0M | -$6.6M | -$8.6M |
| Net income | -$2.1M | -$2.9M | -$20.9M | -$15.2M | -$7.6M |
| Diluted EPS | — | -$0.22 | -$1.48 | -$0.85 | -$0.29 |
| Operating cash flow | -$825,593.00 | -$1.2M | -$13.2M | -$9.2M | -$9.9M |
| Free cash flow | — | — | — | — | — |
| Gross margin | — | 42.7% | 43.6% | 44.9% | 45.4% |
| Operating margin | — | -10.4% | -71.9% | -22.3% | -43.8% |
| Net margin | — | -11.5% | -115.5% | -51.2% | -38.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M | $8.2M | $7.6M | $6.7M | $5.1M | $3.8M | $4.1M | $4.0M |
| Gross profit | $3.3M | $3.7M | $3.3M | $3.2M | $2.3M | $1.6M | $1.8M | $2.0M |
| Operating income | -$2.4M | -$886,000.00 | -$1.1M | -$896,000.00 | -$2.1M | -$3.3M | -$2.2M | -$2.0M |
| Net income | -$2.9M | -$1.5M | -$7.6M | $2.9M | -$8.0M | -$3.6M | $1.1M | -$3.4M |
| Diluted EPS | -$0.16 | -$0.08 | -$0.42 | $0.11 | -$0.31 | -$0.13 | $0.04 | -$0.11 |
| Operating cash flow | -$5.4M | -$1.6M | $469,000.00 | -$1.5M | -$3.4M | -$2.5M | -$2.6M | -$3.7M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 44.3% | 44.9% | 44.0% | 47.2% | 45.2% | 42.7% | 45.2% | 50.8% |
| Operating margin | -32.7% | -10.8% | -14.6% | -13.4% | -41.9% | -88.1% | -54.9% | -49.4% |
| Net margin | -38.3% | -18.4% | -99.8% | 43.2% | -157.3% | -93.7% | 25.7% | -85.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-29 | DiMaio John Michael | Award | 15,000 | $1.73 | $25,950.00 | filing |
| 2026-06-25 | DiMaio John Michael | Award | 14,700 | $1.69 | $24,843.00 | filing |
| 2026-06-24 | DiMaio John Michael | Award | 14,300 | $1.74 | $24,882.00 | filing |
| 2026-05-29 | DiMaio John Michael | Award | 15,000 | $2.12 | $31,800.00 | filing |
| 2026-05-28 | DiMaio John Michael | Award | 2,500 | $2.36 | $5,900.00 | filing |
| 2026-05-26 | DiMaio John Michael | Award | 32,233 | $2.61 | $84,128.13 | filing |
| 2026-05-18 | Cotton Richard John | Award | 8,818 | $2.40 | $21,163.20 | filing |
| 2026-05-15 | DiMaio John Michael | Award | 25,000 | $2.16 | $54,000.00 | filing |
| 2026-05-15 | Cotton Richard John | Award | 5,882 | $2.33 | $13,705.06 | filing |
| 2026-05-15 | DiMaio John Michael | Award | 1,887 | $2.12 | $4,000.44 | filing |
| 2026-04-24 | Snyder Marion Ann | Award | 25,000 | $0.00 | $0.00 | filing |
| 2026-04-24 | DiMaio John Michael | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-04-24 | Cotton Richard John | Award | 29,850 | $0.00 | $0.00 | filing |
| 2026-04-24 | Sadagopan Deepak | Award | 25,000 | $0.00 | $0.00 | filing |
| 2026-04-24 | Capone Vincent S.· Chief Executive Officer | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-03-27 | Capone Vincent S.· Chief Executive Officer | Award | 16,750 | $1.52 | $25,460.00 | filing |
| 2026-03-27 | DiMaio John Michael | Award | 7,619 | $1.58 | $12,038.02 | filing |
Latest 17 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.